 |
 |
Chemistry and Biology: Partners in
Decoding the Genome
March 15-16, 2004
8:30 a.m. - 5:00 p.m. |
Lecture Webcasts
Viewers outside the NIH network can download the latest free version of RealPlayer software from Real Networks. NIH staff can download RealOne Enterprise Desktop for Windows or RealOne for Mac.
March 15, 2003: 8:30 a.m. - 5:00 p.m.
Welcome
Elias Zerhouni, Director, National Institutes of Health
Greetings from Sponsoring Institutes
Jeremy Berg, Director, National Institute of General Medical Sciences
Morning Lectures:
Moderator: John Schwab
National Institute of General Medical Sciences
- Christopher Austin, National Human Genome Research Institute
Small Molecules and the NIH Roadmap
- Daniel Kahne, Princeton University
Glycopeptide Antibiotics and Cell Envelope Biogenesis
- Stuart Schreiber, Harvard University
Dissecting Disease Biology and Advancing Medicine with Small Molecules
- Craig Crews, Yale University
A Small Molecule Approach to Target Identification and Validation
- Carolyn Bertozzi, University of California, Berkeley
Chemical Approaches to Studying Protein Glycosylation
Afternoon Lectures:
Moderator: Christopher Austin
National Human Genome Research Institute
- David Liu, Harvard University
An Evolution-Based Approach to the Creation and Discovery of Functional Synthetic Molecules
- Roger Tsien, University of California, San Diego
Genetically and Proteolytically Targeted Sequences for Imaging from Ultrastructure to Whole Mammals
- Jeremy Berg, National Institute of General Medical Sciences
Chemical Approaches to Zinc Finger Protein Analysis and Design
- Jon Ellman, University of California, Berkeley
Combinatorial Chemistry Targeting Protein Families
Moderator: John Schwab
National Institute of General Medical Sciences
- Gary Glick, University of Michigan
Chemistry and Biology of Immunosuppressive Benzodiazepines
- Stephen Fesik, Abbott Laboratories
NMR-Based Screening of Fragment Libraries for Drug Discovery
March 16, 2003: 8:30 a.m. - 5:00 p.m.
Morning Lectures:
Moderator: John Schwab
National Institute of General Medical Sciences
- Kevan Shokat, University of California, San Francisco
Chemical Tools for Deciphering Cell Signaling Pathways
Moderator: John Beutler
National Cancer Institute
- David Diller, Pharmacopeia
The Role of Computation When Building Collections of Millions of Compounds
- Virginia Cornish, Columbia University
Co-opting Nature for Chemical Diversity
- Dimitris Agrafiotis, 3-Dimensional Pharmaceuticals
Molecular Informatics for the New Drug Discovery Enterprise
Afternoon Lectures:
Moderator: Carole Bewley
National Institute of Diabetes and Digestive and Kidney Diseases
- Chaitan Khosla, Stanford University
Discovery and Development of New Natural Product Drugs: The Example of Polyketides
- Baldimero Olivera, University of Utah
Conus Peptides: From Genes to Venoms to Drugs
- Michael Organ, York University
New Advances in the Screening of Compound Mixtures
Moderator: Christopher Austin
National Human Genome Research Institute
- Alan Verkman, University of California, San Francisco
Drug Discovery in Academia: CFTR Chloride Channel Inhibitors and Activators for Cystic Fibrosis
- Eric Lander, The Broad Institute of MIT and Harvard
Closing Remarks
Alan Guttmacher, Deputy Director, National Human Genome Research Institute
Last Reviewed: September 25, 2007
|
|
|
|
Copyright
Print Version